Status:
COMPLETED
Design of Optimally-diagnostic Skin Test Solutions for Diagnosis of Sensitisation to a Pollen and Dust Mite Mixture.
Lead Sponsor:
Allergopharma GmbH & Co. KG
Conditions:
Type I Allergy
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
Multicenter Skin Prick Test
Eligibility Criteria
Inclusion
- anamnesis referring to suspicion of an IgE-mediated allergy
- positive Skin Prick Test in the medical history to at least one of the investigational allergens with an existing anamnesis
Exclusion
- serious chronic diseases
- Other perennial allergies
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
End Date :
November 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00665483
Start Date
March 1 2007
End Date
November 1 2010
Last Update
November 8 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinikum Darmstadt
Darmstadt, Hesse, Germany, 64297